Screening In Women Army Recruits Shows High Chlamydia Infection Rates

September 10, 1998

Youngest Women Had Highest Prevalence

Nearly one in 10 female new recruits in the Army is infected with Chlamydia trachomatis, according to a study reported in today's New England Journal of Medicine. Left untreated, this Chlamydia infection causes a sexually transmitted disease (STD) that often ends in infertility. Along with a recently reported study from Hopkins on prevalence of infection in teenage girls, the new research suggests Chlamydia is a major threat to the reproductive health of young U.S. women.

The current report from a multi-institutional team led by Hopkins epidemiologists, is a wake-up call, says team leader Charlotte Gaydos, Dr. P.H., because, unlike earlier studies, this one involves adults as well as teens and multiracial populations from varied areas across the country.

Throughout 1996 and 1997, the researchers targeted new female recruits at the Army's induction center at Fort Jackson, S.C., where most of the women come for training. More than 13,204 women volunteered to participate in screening shortly after their arrival. Each filled out a questionnaire on demographics and sexual behavior. Researchers analyzed the recruits' urine samples for Chlamydia DNA using the ligase chain reaction test, a new, highly sensitive way of detecting small amounts of genetic material. They also checked the questionnaires to determine risk factors for getting the infection.

Results of the screening showed that overall, 9.2 percent of the women had Chlamydia, but that figure jumped to more than 12 percent if researchers looked only at 17-year-olds. The risk of having the disease, then, was highest for the youngest recruits. Other factors tied to disease risk were being African-American, being sexually active, not using condoms regularly or having a history of sexually transmitted disease.

"We were surprised," says Gaydos, "at the strength of some of the geographic differences." Georgia, South Carolina, Alabama, Louisiana and Mississippi had a 15 percent prevalence. "That's dramatically different from states like Oregon and Washington, which once had that high rate, but brought it down to less than 5 percent through screening and treatment," says Gaydos.

The study also points out a need for screening in men, Gaydos adds, to stop both new disease and reinfection in treated soldiers. Men are less likely to have untreated disease, she says, because they tend to have symptoms that lead them to a doctor. Somewhere between half and three-quarters of infected men experience a discharge and painful or difficult urination. "We hope this will bring routine screening of both men and women in the Army," says Gaydos.

Funding for the study came from the Department of the Army.

Other researchers are M. Rene Howell and Barbara Pare, of Johns Hopkins; Thomas C. Quinn, M.D., of Hopkins and NIH; Kathryn Clark, M.D., and Joel Gaydos of The Henry M. Jackson Foundation, Rockville, Md.; Dorothy Ellis and Rose Marie Hendrix of the U.S. Army Medical Department Activity, Fort Jackson, S.C; and Kelly McKee Jr, M.D., of the Womack Army Medical Center, Fort Bragg, N.C.
Johns Hopkins Medical Institutions' news releases are available on a PRE-EMBARGOED basis on EurekAlert at, Newswise at and from the Office of Communications and Public Affairs' direct e-mail news release service. To enroll, call (410) 955-4288 or send e-mail to

On a POST-EMBARGOED basis find them at, Quadnet at and ScienceDaily at

Johns Hopkins Medicine

Related Chlamydia Articles from Brightsurf:

Chlamydia: Greedy for glutamine
If chlamydiae want to multiply in a human cell, the first thing they need is a lot of glutamine.

Chlamydia build their own entrance into human cells
Chlamydia, a type of pathogenic bacteria, need to penetrate human cells in order to multiply.

Targeted gene modification in animal pathogenic chlamydia
Researchers at Umeå University (Sweden), in collaboration with researchers at the University of Maryland and Duke University (USA), now for the first time successfully performed targeted gene mutation in the zoonotic pathogen Chlamydia caviae.

How Chlamydia gain access to human cells
Infection biologists at Heinrich Heine University Düsseldorf (HHU) and the University of Freiburg have found out how the LIPP protein discovered in Düsseldorf helps Chlamydia to infect human cells.

Researchers discover how chlamydia takes up new DNA from host
A recent paper by a team of molecular biologists headquartered at the University of Kansas pinpointed a gene that allows chlamydia to take up DNA from its host environment.

Chlamydia in testicular tissue linked to male infertility
The potential impact of undiagnosed sexually transmitted chlamydia infection on men's fertility has been highlighted in a study led by scientists at Queensland University of Technology (QUT), which for the first time found chlamydia in the testicular tissue biopsies of infertile men whose infertility had no identified cause.

New rapid DNA test to diagnose chlamydia infection in koalas
A new DNA test to detect chlamydia infection in koalas which gives on-the-spot results within 30 minutes has been developed in a collaboration between researchers in Brisbane, Australia.

Researchers identify how vaginal microbiome can elicit resistance to chlamydia
The vaginal microbiome is believed to protect women against Chlamydia trachomatis, the etiological agent of the most prevalent sexually transmitted infections (STIs) in developed countries.

The Lancet Infectious Diseases: First ever phase 1 trial of genital chlamydia vaccine finds it is safe and provokes immune response
The first ever chlamydia vaccine to reach phase 1 clinical trial has been found to be safe and able to provoke an immune response, according to a study published in The Lancet Infectious Diseases journal.

Last chlamydia-free koala population may safeguard future of species
The last, large, isolated, healthy chlamydia-free population of koalas in Australia may have been identified on Kangaroo Island, said Morris Animal Foundation-funded researchers at the University of Adelaide.

Read More: Chlamydia News and Chlamydia Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to